AVANT CEO to Present at The Wall Street Analyst Forum on November 11, 2002.Business Editors and Health/Medical Writers BIOWIRE2K NEEDHAM, Mass.--(BUSINESS WIRE)--Nov. 4, 2002 AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that company President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Una S. Ryan, Ph.D., will make a presentation to analysts and portfolio managers at The Wall Street Analyst Forum's Institutional Investors Conference on Monday, November 11, 2002 at 11:40 a.m. Eastern time. The meeting is being held at The Roosevelt Hotel
New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . A live webcast of the 40-minute presentation will be available online via the Investor Information area of AVANT's website at http://www.avantimmune.com and at http://media.corporate-ir.net/media_files/Event/2002/nov/wsaf/111102.htm. An archive of the webcast will be available via AVANT's website for 14 days following the event. AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines. In addition, the company is conducting clinical studies of a proprietary vaccine candidate for cholesterol management. AVANT further leverages the value of its technology portfolio through corporate partnerships. Current collaborations encompass the development of an oral human rotavirus rotavirus /ro·ta·vi·rus/ (ro´tah-vi?rus) any member of the genus Rotavirus. ro´taviral Rotavirus /Ro·ta·vi·rus/ (ro´tah-vi?rus vaccine, vaccines to combat threats of biological warfare biological warfare, employment in war of microorganisms to injure or destroy people, animals, or crops; also called germ or bacteriological warfare. Limited attempts have been made in the past to spread disease among the enemy; e.g. , and vaccines addressed to human food safety and animal health. Additional information on AVANT Immunotherapeutics, Inc. can be obtained through our site on the World Wide Web: http://www.avantimmune.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion